GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » Investments And Advances

ALVO (Alvotech) Investments And Advances : $0.0 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Investments And Advances?

Alvotech's Investments And Advances for the quarter that ended in Sep. 2024 was $0.0 Mil.

Alvotech's quarterly Investments And Advances declined from Mar. 2024 ($18.5 Mil) to Jun. 2024 ($0.0 Mil) but then stayed the same from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil).

Alvotech's annual Investments And Advances declined from Dec. 2021 ($55.3 Mil) to Dec. 2022 ($48.6 Mil) and declined from Dec. 2022 ($48.6 Mil) to Dec. 2023 ($18.5 Mil).


Alvotech Investments And Advances Historical Data

The historical data trend for Alvotech's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Investments And Advances Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
- 56.68 55.31 48.57 18.49

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.04 18.49 18.49 - -

Alvotech Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Alvotech Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.